Hims & Hers Q4 revenue $84.7M (+104% YoY); FY2021 revenue $271.9M; guides FY2022 rev $365-380M

Hims & Hers Health, Inc.

2021-FY EPS reported -$0.58 revenue$271,878,000

Q4 2021 revenue $84.7M (+104% YoY); net loss $(31.2)M vs $(5.2)M loss in Q4 2020.
Full year 2021 revenue $271.9M (+83% YoY); net loss $(107.7)M vs $(18.1)M.
Subscriptions at 609,000, up 95% YoY; gross margin 73% in Q4 vs 77% a year ago.
Provides Q1 and FY2022 guidance: FY2022 revenue $365-380M; Adj EBITDA $(30)M to $(20)M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.